{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:30:13Z","timestamp":1786609813803,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to determine the risk factors for new-onset hepatic steatosis after total pancreatectomy (TP), focusing on muscle loss and sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 100 patients who underwent TP between 2005 and 2024. Nutritional parameters, BMI, muscle volume, and liver status were evaluated. Logistic regression and subgroup analyses were performed to identify the risk factors for hepatic steatosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of hepatic steatosis increased from 3.0% preoperatively to 24.0% at 3\u20136 months after TP. Female patients showed a significantly higher incidence of hepatic steatosis than male patients (37.8% vs. 12.7%, respectively). A multivariate analysis identified female sex (odds ratio: 7.77, 95% confidence interval: 2.03\u201329.8,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009), younger age (0.93, 0.88\u20130.98, 0.011), and higher preoperative BMI (1.28, 1.05\u20131.63, 0.015) as independent risk factors. Among the female patients, a younger age, one-stage TP, greater reductions in SMI, portal vein resection, longer operative time, greater blood loss, and diarrhea at discharge were associated with new-onset hepatic steatosis. However, a lower intraoperative blood loss potentially contributes to recovery from hepatic steatosis after TP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A female sex is a high risk factor for hepatic steatosis after TP. Reducing operative stress and preserving muscle volume may facilitate the prevention and recovery from hepatic steatosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00595-026-03340-x","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:03:44Z","timestamp":1780031024000},"page":"2050-2060","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of reduction in skeletal muscle quantity and sex differences on postoperative hepatic steatosis following total pancreatectomy"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4147-8081","authenticated-orcid":false,"given":"Mitsuhiro","family":"Shimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuhiko","family":"Motoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Umino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koetsu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Douchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"2","key":"3340_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.hpb.2022.11.010","volume":"25","author":"K Johansen","year":"2023","unstructured":"Johansen K, Ghorbani P, Lundgren L, Gilg S, Sandstr\u00f6m P, Sparrelid E, et al. Symptoms and life changes after total pancreatectomy: a qualitative study. HPB (Oxford). 2023;25(2):269\u201377.","journal-title":"HPB (Oxford)"},{"issue":"13","key":"3340_CR2","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/bjs.11296","volume":"106","author":"L Scholten","year":"2019","unstructured":"Scholten L, Stoop TF, Del Chiaro M, Busch OR, van Eijck C, Molenaar IQ, et al. Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg. 2019;106(13):1735\u201346.","journal-title":"Br J Surg"},{"issue":"3","key":"3340_CR3","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.surg.2022.04.031","volume":"172","author":"H Suto","year":"2022","unstructured":"Suto H, Kamei K, Kato H, Misawa T, Unno M, Nitta H, et al. Risk factors associated with hypoglycemic events after total pancreatectomy: A nationwide multicenter prospective study in Japan. Surgery. 2022;172(3):962\u20137.","journal-title":"Surgery"},{"key":"3340_CR4","doi-asserted-by":"crossref","unstructured":"Ito S, Takahashi A, Ueno H, Takiguchi S, Kajiwara Y, Kakeji Y et al. Annual report on National Clinical Database 2021 for gastroenterological surgery in Japan. Annals of gastroenterological surgery. 2025;9(1):32\u201359.","DOI":"10.1002\/ags3.12868"},{"key":"3340_CR5","doi-asserted-by":"crossref","unstructured":"Unno M, Motoi F, Matsuyama Y, Satoi S, Toyama H, Matsumoto I et al. Neoadjuvant Chemotherapy with Gemcitabine and S-1 versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II\/III Prep-02\/JSAP05 Trial. Annals of surgery. 2025.","DOI":"10.1097\/SLA.0000000000006730"},{"key":"3340_CR6","doi-asserted-by":"crossref","unstructured":"Bai X, Li X, Chen Y, Qiao G, Zhang Q, Ma T et al. Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial. Cancer Cell. 2025.","DOI":"10.1016\/j.ccell.2025.09.009"},{"key":"3340_CR7","doi-asserted-by":"crossref","unstructured":"Choi M, Kim NW, Hwang HK, Lee WJ, Kang CM. Repeated Pancreatectomy for Isolated Local Recurrence in the Remnant Pancreas Following Radical Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Pooled Analysis. J Clin Med. 2020;9(12).","DOI":"10.3390\/jcm9123945"},{"issue":"5","key":"3340_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.surg.2018.05.050","volume":"164","author":"S Yamada","year":"2018","unstructured":"Yamada S, Kobayashi A, Nakamori S, Baba H, Yamamoto M, Yamaue H, et al. Resection for recurrent pancreatic cancer in the remnant pancreas after pancreatectomy is clinically promising: Results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Surgery. 2018;164(5):1049\u201356.","journal-title":"Surgery"},{"issue":"4","key":"3340_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/jhbp.1093","volume":"29","author":"H Kato","year":"2022","unstructured":"Kato H, Kamei K, Suto H, Misawa T, Unno M, Nitta H, et al. Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: A first multicenter prospective study in Japan. J Hepato-Biliary-Pancreat Sci. 2022;29(4):428\u201338.","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"issue":"3","key":"3340_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/MPA.0000000000000462","volume":"45","author":"T Hata","year":"2016","unstructured":"Hata T, Ishida M, Motoi F, Sakata N, Yoshimatsu G, Naitoh T, et al. Clinical Characteristics and Risk Factors for the Development of Postoperative Hepatic Steatosis After Total Pancreatectomy. Pancreas. 2016;45(3):362\u20139.","journal-title":"Pancreas"},{"issue":"4","key":"3340_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.pan.2016.04.034","volume":"16","author":"D Hashimoto","year":"2016","unstructured":"Hashimoto D, Chikamoto A, Taki K, Arima K, Yamashita Y, Ohmuraya M, et al. Residual total pancreatectomy: Short- and long-term outcomes. Pancreatology: official J Int Association Pancreatology (IAP) [et al]. 2016;16(4):646\u201351.","journal-title":"Pancreatology: official J Int Association Pancreatology (IAP) [et al]"},{"issue":"35","key":"3340_CR12","doi-asserted-by":"publisher","first-page":"12946","DOI":"10.12998\/wjcc.v10.i35.12946","volume":"10","author":"P Shah","year":"2022","unstructured":"Shah P, Patel V, Ashkar M. De novo non-alcoholic fatty liver disease after pancreatectomy: A systematic review. World J Clin Cases. 2022;10(35):12946\u201358.","journal-title":"World J Clin Cases"},{"issue":"6","key":"3340_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.gassur.2024.03.025","volume":"28","author":"K Sugumar","year":"2024","unstructured":"Sugumar K, Naik L, Hue JJ, Ammori JB, Hardacre JM, Ocuin LM, et al. Risk factors of developing nonalcoholic fatty liver disease after pancreatic resection: a systematic review and meta-analysis. J Gastrointest surgery: official J Soc Surg Aliment Tract. 2024;28(6):983\u201392.","journal-title":"J Gastrointest surgery: official J Soc Surg Aliment Tract"},{"issue":"3","key":"3340_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.51821\/87.3.10078","volume":"87","author":"V D\u2019Cruz","year":"2024","unstructured":"D\u2019Cruz V, De Zutter A, Van den Broecke M, Ribeiro S, Abreu de Carvalho L, Smeets P, et al. Prevalence of metabolic dysfunction-associated fatty liver disease after pancreatic surgery in a historical Belgian cohort and review of the literature. Acta Gastroenterol Belg. 2024;87(3):373\u201380.","journal-title":"Acta Gastroenterol Belg"},{"issue":"3","key":"3340_CR15","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.21037\/jgo-24-700","volume":"16","author":"L Caputo","year":"2025","unstructured":"Caputo L, Richa Y, Balcer K, Beugniez C, Vermersch M, Bourry J, et al. Influence of pre-operative sarcopenia on post-operative hepatic steatosis after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Gastrointest Oncol. 2025;16(3):1305\u201313.","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"3340_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ags3.12554","volume":"6","author":"K Yamamura","year":"2022","unstructured":"Yamamura K, Yamashita YI, Yamao T, Kitano Y, Arima K, Miyata T, et al. Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. Annals gastroenterological Surg. 2022;6(4):555\u201361.","journal-title":"Annals gastroenterological Surg"},{"issue":"2","key":"3340_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00595-019-01866-x","volume":"50","author":"H Okabe","year":"2020","unstructured":"Okabe H, Yamashita YI, Inoue R, Kinoshita S, Itoyama R, Yusa T, et al. Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomy. Surg Today. 2020;50(2):193\u20139.","journal-title":"Surg Today"},{"issue":"3","key":"3340_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jhbp.318","volume":"23","author":"S Satoi","year":"2016","unstructured":"Satoi S, Sho M, Yanagimoto H, Yamamoto T, Akahori T, Kinoshita S, et al. Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial. J Hepato-Biliary-Pancreat Sci. 2016;23(3):167\u201373.","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"issue":"6","key":"3340_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/MPA.0000000000000356","volume":"44","author":"Y Kishi","year":"2015","unstructured":"Kishi Y, Shimada K, Nara S, Esaki M, Kosuge T. Administration of Pancrelipase as Effective Treatment for Hepatic Steatosis After Pancreatectomy. Pancreas. 2015;44(6):983\u20137.","journal-title":"Pancreas"},{"issue":"3","key":"3340_CR20","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1002\/j.2040-4603.2023.tb00269.x","volume":"13","author":"K Uehara","year":"2023","unstructured":"Uehara K, Santoleri D, Whitlock AEG, Titchenell PM. Insulin Regulation of Hepatic Lipid Homeostasis. Compr Physiol. 2023;13(3):4785\u2013809.","journal-title":"Compr Physiol"},{"issue":"5","key":"3340_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ags3.12572","volume":"6","author":"M Tsunematsu","year":"2022","unstructured":"Tsunematsu M, Gocho T, Yanagaki M, Shirai Y, Haruki K, Furukawa K, et al. The impact of postoperative exocrine index on non-alcoholic fatty liver disease following pancreaticoduodenectomy. Annals gastroenterological Surg. 2022;6(5):704\u201311.","journal-title":"Annals gastroenterological Surg"},{"issue":"6","key":"3340_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jamcollsurg.2020.08.761","volume":"231","author":"K Yasukawa","year":"2020","unstructured":"Yasukawa K, Shimizu A, Yokoyama T, Kubota K, Notake T, Seki H, et al. Preventive Effect of High-Dose Digestive Enzyme Management on Development of Nonalcoholic Fatty Liver Disease after Pancreaticoduodenectomy: A Randomized Controlled Clinical Trial. J Am Coll Surg. 2020;231(6):658\u201369.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"3340_CR23","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Letafatkar N, Norouzi N, Joukar F, Habibi A, Javid M, et al. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries. Arch Med Res. 2024;55(6):103043.","journal-title":"Arch Med Res"},{"issue":"12","key":"3340_CR24","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/bjs.9893","volume":"102","author":"S Levolger","year":"2015","unstructured":"Levolger S, van Vugt JL, de Bruin RW, JN IJ. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg. 2015;102(12):1448\u201358.","journal-title":"Br J Surg"},{"key":"3340_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers16193356","volume":"16","author":"AJ Lainez Ramos-Bossini","year":"2024","unstructured":"Lainez Ramos-Bossini AJ, Gamez Martinez A, Luengo Gomez D, Valverde-Lopez F, Melguizo C, Prados J. Prevalence of Sarcopenia Determined by Computed Tomography in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Cancers. 2024;16:19.","journal-title":"Cancers"},{"issue":"11","key":"3340_CR26","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.2337\/db12-0206","volume":"61","author":"C Flannery","year":"2012","unstructured":"Flannery C, Dufour S, Rab\u00f8l R, Shulman GI, Petersen KF. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes. 2012;61(11):2711\u20137.","journal-title":"Diabetes"},{"issue":"11","key":"3340_CR27","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1136\/gut.2006.091454","volume":"55","author":"IN Guha","year":"2006","unstructured":"Guha IN, Parkes J, Roderick PR, Harris S, Rosenberg WM. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease. Gut. 2006;55(11):1650\u201360.","journal-title":"Gut"},{"issue":"2","key":"3340_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.surg.2016.04.009","volume":"160","author":"T Sato","year":"2016","unstructured":"Sato T, Matsuo Y, Shiga K, Morimoto M, Miyai H, Takeyama H. Factors that predict the occurrence of and recovery from non-alcoholic fatty liver disease after pancreatoduodenectomy. Surgery. 2016;160(2):318\u201330.","journal-title":"Surgery"},{"issue":"1","key":"3340_CR29","doi-asserted-by":"publisher","first-page":"17602","DOI":"10.1038\/s41598-025-00377-9","volume":"15","author":"JH Park","year":"2025","unstructured":"Park JH, Park HY. Association between muscular strength, abdominal obesity, and incident nonalcoholic fatty liver disease in a Korean population. Sci Rep. 2025;15(1):17602.","journal-title":"Sci Rep"},{"key":"3340_CR30","doi-asserted-by":"publisher","first-page":"1457598","DOI":"10.3389\/fendo.2024.1457598","volume":"15","author":"Y Xuan","year":"2024","unstructured":"Xuan Y, Wu D, Zhang Q, Yu Z, Yu J, Zhou D. Elevated ALT\/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States. Front Endocrinol (Lausanne). 2024;15:1457598.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3340_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12944-020-01419-z","volume":"19","author":"Y Zou","year":"2020","unstructured":"Zou Y, Zhong L, Hu C, Sheng G. Association between the alanine aminotransferase\/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. Lipids Health Dis. 2020;19(1):245.","journal-title":"Lipids Health Dis"},{"key":"3340_CR32","unstructured":"Pillai AVA, Das MT, Rajan R. R, V RA. Change in liver fat content in patients following pancreatic resections. Indian J Gastroenterol. 2025."},{"issue":"1","key":"3340_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pan.2024.12.011","volume":"25","author":"R Shintakuya","year":"2025","unstructured":"Shintakuya R, Uemura K, Sumiyoshi T, Okada K, Baba K, Harada T, et al. Significance of administering postoperative pancreatic enzyme replacement therapy for fat digestion and absorption functions in patients who underwent initial total pancreatectomy. Pancreatology: official J Int Association Pancreatology (IAP) [et al]. 2025;25(1):160\u20136.","journal-title":"Pancreatology: official J Int Association Pancreatology (IAP) [et al]"},{"issue":"1","key":"3340_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41392-025-02562-8","volume":"11","author":"Q Yu","year":"2026","unstructured":"Yu Q, Song H, Shi XY, Zhu L, Liang Y, Gong RN, et al. Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory factor-CD44 axis. Signal Transduct Target therapy. 2026;11(1):32.","journal-title":"Signal Transduct Target therapy"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03340-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-026-03340-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03340-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:01:11Z","timestamp":1786608071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-026-03340-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3340"],"URL":"https:\/\/doi.org\/10.1007\/s00595-026-03340-x","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed on human participants were in accordance with the ethical standards of the Institutional Review Board of Tohoku University Graduate School of Medicine (2024-1-200) and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants included in the study before surgery, in accordance with our institutional guidelines. Additional informed consent for inclusion in the retrospective study was not required because anonymized clinical data were used. An explanation of the patients\u2019 right to refuse to participate in the study was posted on our institute\u2019s website.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}